帐单 发表于 2025-3-25 05:39:22

http://reply.papertrans.cn/2/162/16180/16180-21.png

cardiopulmonary 发表于 2025-3-25 09:40:59

http://reply.papertrans.cn/2/162/16180/16180-22.png

切掉 发表于 2025-3-25 14:16:24

Submitted on: 18 June 2024.
Revised on: 08 October 2024.
Accepted on: 26 October 2024.

___________________JOURNAL OF CONTROLLED RELEASE---ELSEVIER

死亡率 发表于 2025-3-25 18:06:37

Submitted on: 22 February 2003.
Revised on: 27 April 2003.
Accepted on: 09 June 2003.

___________________JOURNAL OF CONTROLLED RELEASE---ELSEVIER

Lipoma 发表于 2025-3-25 23:40:26

http://reply.papertrans.cn/2/162/16180/16180-25.png

cruise 发表于 2025-3-26 00:11:42

Submitted on: 19 April 2015.
Revised on: 18 July 2015.
Accepted on: 29 July 2015.

___________________JOURNAL OF CONTROLLED RELEASE---ELSEVIER

neutral-posture 发表于 2025-3-26 07:10:17

http://reply.papertrans.cn/2/162/16180/16180-27.png

uveitis 发表于 2025-3-26 10:37:23

Submitted on: 08 August 2024.
Revised on: 02 December 2024.
Accepted on: 23 December 2024.

___________________JOURNAL OF CONTROLLED RELEASE---ELSEVIER

boisterous 发表于 2025-3-26 15:14:50

Submitted on: 11 May 2001.
Revised on: 21 June 2001.
Accepted on: 20 July 2001.

___________________JOURNAL OF CONTROLLED RELEASE---ELSEVIER

obscurity 发表于 2025-3-26 19:48:19

http://reply.papertrans.cn/2/162/16180/16180-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊JOURNAL OF CONTROLLED RELEASE 2024/2025影响因子:10.598 (J CONTROL RELEASE) (0168-3659). (PHARMACOLOGY & PHARMACY)(药理学